Daily News Podcast

Lorcaserin shows cardiovascular safety

Publish date: August 27, 2018

 

Lorcaserin is the first weight-loss drug proven to have cardiovascular safety. Also today, live attenuated flu vaccine gets the nod for upcoming flu season, PCSK9 inhibition helps patients with metabolic syndrome, and breastfeeding may reduce the risk of stroke decades later. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa
Apple Podcasts
Spotify

Recommended Reading

The moves may not be smooth, but dance dad, dance
MDedge Psychiatry
Girl reunites with mother amid uncertainty
MDedge Psychiatry
Cardiovascular risk management supported for type 2 diabetes
MDedge Psychiatry
An epidemic of non-alcoholic fatty liver disease
MDedge Psychiatry
The human mind: Wasted or cultivated?
MDedge Psychiatry
Sleepio app tied to reducing insomnia, depression
MDedge Psychiatry
Michael Gitlin: Stimulants
MDedge Psychiatry
5 digital HIPAA myths
MDedge Psychiatry
Screen for cervical cancer based on age, risk
MDedge Psychiatry
Is it time for PCPs to take over chronic HCV?
MDedge Psychiatry